Elucidating the integrative role and possible molecular mechanisms of Salvia miltiorrhiza ingredients and gut microbiota-derived metabolites in alleviating pyroptosis-mediated hepatic ischemia–reperfusion injury through network pharmacology
Source abstract
Abstract
Currently, therapeutic options for hepatic ischemia–reperfusion injury (HIRI) remain limited and challenging. An emerging alternative involves the combination of ingredients from traditional Chinese medicine (TCM) and beneficial gut microbiota (GM) metabolites. This study integrates ingredients of Salvia miltiorrhiza (SM) and metabolites of GM to assess their combined therapeutic efficacy against HIRI through pyroptosis using network pharmacology. Twenty-nine final targets were recognized as key proteins responsible for the alleviation of HIRI by SM ingredients and GM metabolites through pyroptosis, with GAPDH, AKT1, ILB1 emerging as central targets in the protein–protein interaction (PPI) network. The Toll-like receptor (TLR), NOD-like receptor (NLR), IL-17, TNF and MAPK signalling pathways were identified as key pathways in the therapeutic effects of SM ingredients and GM metabolites. Eight microRNAs (miRNAs) were predicted to be potential miRNAs exerting the most influence. Four SM ingredients and 11 GM metabolites were identified as non-toxic, promising candidates against HIRI. Moreover, the results of molecular docking showed all compounds were well combined with the corresponding proteins. This study highlights the therapeutic potential of TCM and beneficial GM in HIRI treatment and provides a foundational dataset for future research on their combined application. Further in vitro and in vivo studies are needed to validate these findings.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Inflammasome and immune disorders · Drug-Induced Hepatotoxicity and Protection · Liver Disease Diagnosis and Treatment
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmacy, School of Medicine, Taizhou Central Hospital (Taizhou University Hospital), Taizhou University
Department of Clinical Medicine, School of Medicine, Taizhou University
Department of Pharmacy, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), School of Medicine, Taizhou University
Funding
the Special Support Plan Fund of Taizhou for High-level Talent · the Science and Technology Plan Project of Taizhou
References (70)
Show source-provided references
1. 10.3350/cmh.2024.022210.3350/cmh.2024.0222 ↗
2. 10.1016/j.lfs.2006.06.02410.1016/j.lfs.2006.06.024 ↗
3. 10.1016/j.transproceed.2007.09.04410.1016/j.transproceed.2007.09.044 ↗
4. 10.1152/ajpgi.2000.279.1.G16310.1152/ajpgi.2000.279.1.G163 ↗
5. 10.3390/cells810113110.3390/cells8101131 ↗
6. 10.1016/j.heliyon.2024.e3248010.1016/j.heliyon.2024.e32480 ↗
7. 10.3390/cells1114222210.3390/cells11142222 ↗
8. 10.1038/s41579-023-00904-310.1038/s41579-023-00904-3 ↗
9. 10.24976/Discov.Med.202436189.18110.24976/Discov.Med.202436189.181 ↗
10. 10.1016/j.apsb.2021.05.02910.1016/j.apsb.2021.05.029 ↗
11. 10.1016/j.ijbiomac.2025.14071710.1016/j.ijbiomac.2025.140717 ↗
12. 10.3389/fimmu.2022.86250310.3389/fimmu.2022.862503 ↗
13. 10.1016/S1875-5364(15)30002-910.1016/S1875-5364(15)30002-9 ↗
14. 10.1016/j.jep.2023.11666710.1016/j.jep.2023.116667 ↗
15. 10.3389/fphar.2020.54142610.3389/fphar.2020.541426 ↗
16. 10.1016/j.phymed.2025.15637810.1016/j.phymed.2025.156378 ↗
17. Qian W, Wang Z, Xu T, et al. Anti-apoptotic effects and mechanisms of salvianolic acid A on cardiomyocytes in ischemia–reperfusion injury. Histol Histopathol. 2019;34(3):223–231.
18. 10.3748/wjg.v9.i9.204010.3748/wjg.v9.i9.2040 ↗
19. 10.2741/46110.2741/461 ↗
20. Xing HC, Li LJ, Xu KJ, et al. Effects of Salvia miltiorrhiza on intestinal microflora in rats with ischemia/reperfusion liver injury. Hepatobiliary Pancreat Dis Int. 2005;4(2):274–280.
21. 10.4093/dmj.2019.004210.4093/dmj.2019.0042 ↗
22. 10.3748/wjg.v28.i43.613110.3748/wjg.v28.i43.6131 ↗
23. 10.1016/j.biopha.2024.11705510.1016/j.biopha.2024.117055 ↗
24. 10.1021/acs.jcim.3c0036510.1021/acs.jcim.3c00365 ↗
25. 10.1038/srep4271710.1038/srep42717 ↗
26. 10.1016/j.ddtec.2004.11.00710.1016/j.ddtec.2004.11.007 ↗
27. 10.1080/1062936X.2010.50229510.1080/1062936X.2010.502295 ↗
28. 10.1080/17460441.2016.121696710.1080/17460441.2016.1216967 ↗
29. 10.1186/s13321-016-0130-x10.1186/s13321-016-0130-x ↗
30. 10.1093/nar/gkz38210.1093/nar/gkz382 ↗
31. 10.1093/nar/gkab78610.1093/nar/gkab786 ↗
32. 10.1002/cpbi.510.1002/cpbi.5 ↗
33. 10.1016/j.heliyon.2024.e3434810.1016/j.heliyon.2024.e34348 ↗
34. 10.1093/nar/gkac83310.1093/nar/gkac833 ↗
35. 10.1093/nar/gkac100010.1093/nar/gkac1000 ↗
36. 10.1186/gb-2003-4-5-p310.1186/gb-2003-4-5-p3 ↗
37. 10.1371/journal.pone.029423610.1371/journal.pone.0294236 ↗
38. 10.1093/nar/gkw28810.1093/nar/gkw288 ↗
39. 10.1093/bib/bbac53410.1093/bib/bbac534 ↗
40. 10.1093/nar/gkab25510.1093/nar/gkab255 ↗
41. 10.1093/nar/28.1.23510.1093/nar/28.1.235 ↗
42. 10.3389/fcell.2021.63836610.3389/fcell.2021.638366 ↗
43. 10.3390/ijms23221439610.3390/ijms232214396 ↗
44. 10.1111/j.1440-1681.2011.05599.x10.1111/j.1440-1681.2011.05599.x ↗
45. 10.1016/j.intimp.2024.11248810.1016/j.intimp.2024.112488 ↗
46. 10.1155/2022/100169210.1155/2022/1001692 ↗
47. 10.3389/fphar.2021.75625910.3389/fphar.2021.756259 ↗
48. 10.1038/s41598-023-47918-810.1038/s41598-023-47918-8 ↗
49. 10.3389/fimmu.2019.0294510.3389/fimmu.2019.02945 ↗
50. 10.1080/0886022X.2025.248814010.1080/0886022X.2025.2488140 ↗
51. 10.1002/hep.2659210.1002/hep.26592 ↗
52. 10.1021/acs.jafc.2c0758110.1021/acs.jafc.2c07581 ↗
53. 10.7717/peerj.1190910.7717/peerj.11909 ↗
54. 10.1002/JLB.3MA0520-716R10.1002/JLB.3MA0520-716R ↗
55. 10.2147/JIR.S39660410.2147/JIR.S396604 ↗
56. 10.1111/sji.1312410.1111/sji.13124 ↗
57. 10.1038/s41569-023-00946-310.1038/s41569-023-00946-3 ↗
58. 10.4110/in.2023.23.e4610.4110/in.2023.23.e46 ↗
59. 10.1111/cpr.1282910.1111/cpr.12829 ↗
60. 10.1016/j.intimp.2024.11358910.1016/j.intimp.2024.113589 ↗
61. 10.1016/j.hbpd.2022.07.00810.1016/j.hbpd.2022.07.008 ↗
62. 10.3390/biology1202030810.3390/biology12020308 ↗
63. 10.3892/etm.2020.935710.3892/etm.2020.9357 ↗
64. 10.5152/tjg.2022.2116910.5152/tjg.2022.21169 ↗
65. 10.1007/s10753-022-01652-x10.1007/s10753-022-01652-x ↗
66. Chen J, Li WL, Wu JL, et al. Euscaphic acid, a new hypoglycemic natural product from Folium Eriobotryae. Pharmazie. 2008;63(10):765–767.
67. 10.1080/08923973.2022.212192610.1080/08923973.2022.2121926 ↗
68. 10.1016/j.biopha.2024.11650010.1016/j.biopha.2024.116500 ↗
69. 10.1093/jpp/rgab15310.1093/jpp/rgab153 ↗
70. 10.3892/etm.2019.718910.3892/etm.2019.7189 ↗